Neutrolis Inc

📍 Cambridge, United States🗓 Founded 2017👥 12 employees💰 Last funded Sep 2021
Biotechnology🌐 neutrolis.com
Website LinkedIn
Neutrolis, Inc. is a biotechnology company developing therapeutics that target neutrophils, the most abundant immune cell in our body. Neutrolis’ lead program targets Neutrophil Extracellular Traps (NETs). NETs are a fundamental arm of the innate immune system and play an important role in chronic and acute diseases. Based in Cambridge, MA, Neutrolis was founded by two of the earliest and most cited leaders in the NETs field and supported by seasoned business leaders.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2017
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
Hong Kong
1
Frequently asked questions
Who invested in Neutrolis Inc?
Neutrolis Inc has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did Neutrolis Inc last raise funding?
The most recent investment in Neutrolis Inc recorded on gritt.io was in September 2021.
When was Neutrolis Inc founded?
Neutrolis Inc was founded in 2017.
What industry is Neutrolis Inc in?
Neutrolis Inc operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Neutrolis Inc based?
Neutrolis Inc is headquartered in Cambridge, United States.